Therapeutic Potential of Black Seed and Opium Poppy Oils in Mitigating Morphine Withdrawal Syndrome in an Animal Model

Document Type : Original Article

Authors

1 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

3 Department of Pharmacognosy and Traditional Pharmacy, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

10.34172/ahj.1587

Abstract

Background: Dependence and withdrawal syndrome caused by opioids are the most important and unambiguous factors in the clinical use of narcotic painkillers. Some evidence indicates the beneficial effects of herbal fragments in attenuating this complication. In the current study, the impact of black seed oil (BSO) and opium poppy oil (OPO) was investigated on the symptoms of morphine withdrawal syndrome in mice.
Methods: For three days, morphine was administrated to induce dependence in mice. To induce the withdrawal syndrome, on the 4th day, naloxone was injected. Thirty minutes before naloxone administration, various doses of BSO (250, 500 mg/kg) and OPO (150, 300 mg/kg) were given as active treatments, along with saline and clonidine, to 6 groups. The data obtained were compared to those from other groups that received clonidine and saline separately (n = 8). The levels of excitability, anxiety-like behavior, and pain threshold were assessed using the open field test, elevated plus maze (EPM), and hot plate tests.
Findings: Clonidine and both studied doses of BSO significantly increased the presence of mice in the light arm of the EPM (P < 0.05). The irritability and locomotion in animals with withdrawal syndrome in the groups that received BSO and clonidine considerably reduced and the pain sensitivity was elevated (P < 0.05). There was no significant difference between the BSO and clonidine groups. OPO did not significantly improve symptoms.
Conclusion: The present results revealed that the administration of BSO is effective in relieving the manifestations of morphine withdrawal syndrome, including anxiety, irritability, and motor activity, in a manner comparable to clonidine.

Keywords


  1. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943-53. doi: 10.1056/NEJMra025411.
  2. Fuhrmann-Berger J. The economic impact of opioid addiction. Strategic HR Rev. 2018;17(4):198-203. doi: 10.1108/shr-05- 2018-0040.
  3. Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30(3):300-5. doi: 10.1111/j.1465- 3362.2010.00271.x.
  4. Eidson LN, Murphy AZ. Inflammatory mediators of opioid tolerance: implications for dependency and addiction. Peptides. 2019;115:51-8. doi: 10.1016/j.peptides.2019.01.003.
  5. Bawa G, Mahajan R, Mehta M, Satija S, Vyas M, Sharma N, et al. Herbal drugs for the treatment of opioid withdrawal syndrome: a mini review. Plant Arch. 2019;19(Suppl 2):1005-11.
  6. Solhi H, Salehi B, Alimoradian A, Pazouki S, Taghizadeh M, Saleh AM, et al. Beneficial effects of Rosmarinus officinalis for treatment of opium withdrawal syndrome during addiction treatment programs: a clinical trial. Addict Health. 2013;5(3-4):90-4.
  7. Samarghandian S, Farkhondeh T, Samini F. A review on possible therapeutic effect of Nigella sativa and thymoquinone in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2018;17(6):412-20. doi: 10.2174/18715273176661 80702101455.
  8. Islam MH, Ahmad IZ, Salman MT. Neuroprotective effects of Nigella sativa extracts during germination on central nervous system. Pharmacogn Mag. 2015;11(Suppl 1):S182-9. doi: 10.4103/0973-1296.157729.
  9. Bordoni L, Fedeli D, Nasuti C, Maggi F, Papa F, Wabitsch M, et al. Antioxidant and anti-inflammatory properties of Nigella sativa oil in human pre-adipocytes. Antioxidants (Basel). 2019;8(2):51. doi: 10.3390/antiox8020051.
  10. Mani D, Dhawan SS. Scientific basis of therapeutic uses of opium poppy (Papaver somniferum) in Ayurveda. Acta Hortic. 2014;1036:175-80. doi: 10.17660/ActaHortic.2014.1036.20.
  11. Hayat MT, Hameed U, Zia-Ul-Haq M. Opium poppy. In: Zia-Ul-Haq M, Al-Huqail AA, Riaz M, Gohar UF, eds. Essentials of Medicinal and Aromatic Crops. Cham: Springer International Publishing; 2023. p. 935-64. doi: 10.1007/978-3-031-35403-8_36.
  1. Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020;395(10241):1938- 48. doi: 10.1016/s0140-6736(20)30852-7.
  2. Abbasi Maleki S, Mosavi SZ, Rahbari Farzoo M, Khayatnouri MH. Evaluation of the effect of citalopram on morphine withdrawal signs in male mice. J Rafsanjan Univ Med Sci. 2012;11(5):427-36. [Persian].
  3. Kuhn BN, Kalivas PW, Bobadilla AC. Understanding addiction using animal models. Front Behav Neurosci. 2019;13:262. doi: 10.3389/fnbeh.2019.00262.
  4. Pedrón VT, Varani AP, Balerio GN. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice. Synapse. 2016;70(5):187-97. doi: 10.1002/ syn.21886.
  5. Moradi M, Mashhadi Akbar Boojar M, Saberi M, Rahimi Salkuyeh HR, Ghorbani M, Amanpour H, et al. Comparison of analgesic effect of rosmarinic acid with piroxicam in mice. Int J Basic Sci Med. 2022;7(1):28-33. doi: 10.34172/ ijbsm.2022.06.
  6. Ozdemir D, Meyer J, Kieffer BL, Darcq E. Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice. Sci Rep. 2024;14(1):9767. doi: 10.1038/s41598-024-60759-3.
  7. Streetz VN, Gildon BL, Thompson DF. Role of clonidine in neonatal abstinence syndrome: a systematic review. Ann Pharmacother. 2016;50(4):301-10. doi: 10.1177/1060028015626438.
  8. Verma R, Sartaj A, Qizilbash FF, Ghoneim MM, Alshehri S, Imam SS, et al. An overview of the neuropharmacological potential of thymoquinone and its targeted delivery prospects for CNS disorder. Curr Drug Metab. 2022;23(6):447-59. doi: 10.2174/1389200223666220608142506.
  9. Agrawal N, Kumar S, Gupta N. Pharmacological benefits of Papaver somniferum : nutritional and medicinal aspects of opium poppy. In: Pharmacological Benefits of Natural Agents. IGI Global; 2023. p. 298-317.
  10. Ajao MS, Imam A, Amin A, Abdulmajeed WI, Ajibola MI, Alli- Oluwafuyi A, et al. Black seed oil improves motor and anxiety-like behaviors and cerebellar cyto-architectonic in adult male Wistar rats. Niger J Neurosci. 2016;8(1-2):8-14.
  11. Firdaus F, Zafeer MF, Ahmad M, Afzal M. Anxiolytic and anti-inflammatory role of thymoquinone in arsenic-induced hippocampal toxicity in Wistar rats. Heliyon. 2018;4(6):e00650. doi: 10.1016/j.heliyon.2018.e00650.
  12. Hajipour S, Farbood Y, Dianat M, Rashno M, Khorsandi LS, Sarkaki A. Thymoquinone improves behavioral and biochemical deficits in hepatic encephalopathy induced by thioacetamide in rats. Neurosci Lett. 2021;745:135617. doi: 10.1016/j.neulet.2020.135617.
  13. Hosseinzadeh H, Parvardeh S, Masoudi A, Moghimi M, Mahboobifard F. Attenuation of morphine tolerance and dependence by thymoquinone in mice. Avicenna J Phytomed. 2016;6(1):55-66.
  14. Nomier Y, Khuwaja G, Penakalapati SR, Alshahrani S, Rehman Z, Khawaji R, et al. Ethnopharmacological evaluation of poppy seed oil in combination with tramadol on behavioral paradigm and on dopamine, and cytokines levels. Eur Rev Med Pharmacol Sci. 2023;27(5):2077-90. doi: 10.26355/ eurrev_202303_31579.
  15. Knutsen HK, Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S, et al. Update of the scientific opinion on opium alkaloids in poppy seeds. EFSA J. 2018;16(5):e05243. doi: 10.2903/j.efsa.2018.5243.
  16. Ward P, Moss HG, Brown TR, Kalivas P, Jenkins DD. N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats. Pediatr Res. 2020;88(1):77-84. doi: 10.1038/s41390-019-0728-6.
  17. Pace MC, Mazzariello L, Passavanti MB, Sansone P, Barbarisi M, Aurilio C. Neurobiology of pain. J Cell Physiol. 2006;209(1):8-12. doi: 10.1002/jcp.20693.
  18. Arslan N, Büyükgöçmen R, Gümüşçü A. Oil and morphine contents of Turkish poppy populations. Tarla Bitkileri Merkez Araştırma Enstitüsü Dergisi. 2000;9(1-2):56-60.
  19. Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care. 2014;8(2):143-51. doi: 10.1097/ spc.0000000000000055.
  20. El-Mahmoudy A, Matsuyama H, Borgan MA, Shimizu Y, El- Sayed MG, Minamoto N, et al. Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages. Int Immunopharmacol. 2002;2(11):1603-11. doi: 10.1016/s1567-5769(02)00139-x.
  21. Talaei SA, Banafshe HR, Moravveji A, Shabani M, Shirazi Tehrani S, Abed A. Anti-nociceptive effect of black seed oil on an animal model of chronic constriction injury. Res Pharm Sci. 2022;17(4):383-91. doi: 10.4103/1735-5362.350239.
  22. Anvari M, Seddigh A, Shafei MN, Rakhshandeh H, Talebi AH, Tahani MR, et al. Nigella sativa extract affects conditioned place preference induced by morphine in rats. Anc Sci Life. 2012;32(2):82-8. doi: 10.4103/0257-7941.118537.
  23. Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the Nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iran J Pharm Res. 2014;13(1):227-34.
  24. Anaeigoudari A. Antidepressant and anti-nociceptive effects of Nigella sativa and its main constituent, thymoquinone: a literature review. Asian Pac J Trop Biomed. 2022;12(12):495-503.
  25. Fauzi NF, Abu Bakar NH, Mohamad N, Hadzrullathfi S, Syed Omar SH, Ismail MZ, et al. Nigella sativa effects on neurotransmitter systems: potential treatment for drug tolerance and dependence. Int J Pharm Res Allied Sci. 2018;7(1):196-200.
  26. Malik T, Hasan S, Pervez S, Fatima T, Haleem DJ. Nigella sativa oil reduces extrapyramidal symptoms (EPS)-like behavior in haloperidol-treated rats. Neurochem Res. 2016;41(12):3386- 98. doi: 10.1007/s11064-016-2073-z.
  27. Bepari A, Parashiva Murthy BM, Niazi S. Evaluation of anticonvulsant activity of volatile oil extract of Nigella sativa seeds by chemically induced seizure model in albino rats. Int J Basic Clin Pharmacol. 2016;5:1300-7. doi: 10.18203/2319- 2003.ijbcp20162176.
  28. Rayhan MA, Yousuf SA, Rayhan J, Khengari EM, Nawrin K, Billah MM. Black seed honey—a powerful ingredient of prophetic medicine; its neuropharmacological potential. J Apither. 2019;5(2):18-26. doi: 10.5455/ja.20190531094932.
  29. Perveen T, Haider S, Kanwal S, Haleem DJ. Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. Pak J Pharm Sci. 2009;22(2):139-44.
  30. Sahak MK, Kabir N, Abbas G, Draman S, Hashim NH, Hasan Adli DS. The role of Nigella sativa and its active constituents in learning and memory. Evid Based Complement Alternat Med. 2016;2016:6075679. doi: 10.1155/2016/6075679.
  31. Yimer EM, Tuem KB, Karim A, Ur-Rehman N, Anwar F. Nigella sativa (black cumin): a promising natural remedy for wide range of illnesses. Evid Based Complement Alternat Med. 2019;2019:1528635. doi: 10.1155/2019/1528635.